90%Confidence
0Views
FDASource
2026-04-17Date
Summary
Another Appco Pharma cGMP deviation for Prazosin 2mg capsules confirms systemic quality control problems affecting multiple product strengths. This pattern suggests deeper manufacturing issues that could impact Biocon Pharma's entire Prazosin product line.
Actionable: Consider diversifying Prazosin sourcing away from Biocon/Appco until quality issues are resolved.
AI Confidence: 90%
Data Points
firmAppco Pharma LLC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productPrazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now